Latest News by Industry
WOODCLIFF LAKE, N.J. (AP) — WOODCLIFF LAKE, N.J. (AP) — Eagle Pharmaceuticals Inc. (EGRX) on Monday reported fourth-quarter net income of $8.2 million, after reporting a loss in the same period a year earlier.
The Woodcliff Lake, New Jersey-based company said it had net income of 62 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, were $1.10 per share.
The specialty pharmaceutical company posted revenue of $60.7 million in the period.
For the year, the company reported net income of $35.6 million, or $2.73 per share, swinging to a profit in the period. Revenue was reported as $316.6 million.
Eagle Pharmaceuticals expects full-year earnings in the range of $4.20 to $4.53 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a EGRX">Zacks stock report on EGRX at https://www.zacks.com/ap/EGRX